Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stockwatch: Sugar-coated earnings ironies

This article was originally published in Scrip

Executive Summary

Last week saw the start of the deluge of third-quarter earnings reports from pharmaceutical, biotechnology and medical device companies. The first half of the week was punctuated by poor reports, some of which were advertised as the opposite by the investment bank analysts that cover the companies. The motives for sugar-coating bad financial reports are reasonably obvious, making it all the more embarrassing when it happens. Thankfully, the companies reporting towards the end of the week removed the need for any more sell-side fiction.

Advertisement
Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC026734

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel